Literature DB >> 22832644

Bladder hemangioma: case report.

Octavio A Castillo1, Alejandro Foneron, Francisco Sepúlveda, Rafael Sánchez-Salas, Virginia Martínez.   

Abstract

OBJECTIVE: Bladder hemangioma is a benign rare lesion. There are no pathognomonic clinical signs and management is controversial due to the bleeding risk. We report a bladder cavernous hemangioma resolved using bipolar transurethral resection.
METHODS: We review the case of a female patient who presented with asymptomatic hematuria. On cystoscopy we discovered a reddish sessile lesion compatible with bladder hemangioma. We describe the diagnostic work up, surgical management and review other therapeutic alternatives for these lesions.
RESULTS: Fifty five year old healthy female patient consulting for total painless hematuria. Cystoscopic evaluation revealed a 1 cm diameter sessile reddish elevated lesion near the bladder neck. We performed a transurethral endoscopic resection using the Gyrus Bipolar resectoscope®. Pathologic report concluded cavernous angioma.
CONCLUSION: Bladder hemangiomas are benign and rare lesions. Clinical presentation has no pathognomonic signs although gross painless hematuria is the most frequent complain. Management is controversial due to the bleeding risk of this highly vascularized lesion. However, it appears that small lesions could be treated using transurethral resection. Although they have a benign course, follow up is mandatory to detect recurrence or residual disease.

Entities:  

Mesh:

Year:  2012        PMID: 22832644

Source DB:  PubMed          Journal:  Arch Esp Urol        ISSN: 0004-0614            Impact factor:   0.436


  2 in total

1.  Hemangioma of the urinary bladder: an atypical location.

Authors:  Camila Soares Moreira de Sousa; Ivo Lima Viana; Carla Lorena Vasques Mendes de Miranda; Breno Braga Bastos; Ilan Lopes Leite Mendes
Journal:  Radiol Bras       Date:  2017 Jul-Aug

2.  Haemangiomas in the urinary bladder: Two case reports.

Authors:  Gui-Cheng Zhao; Chang-Xing Ke
Journal:  World J Clin Cases       Date:  2021-06-06       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.